Skip to content

Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair

Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02128646
Enrollment
19
Registered
2014-05-01
Start date
2014-04-30
Completion date
2017-01-31
Last updated
2025-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain Management, Exparel, Abdominal Hernia Repair, Laparoscopic Surgery

Brief summary

The purpose of this study is to learn how well Liposomal Bupivacaine (Exparel™) controls post-operative pain in patients undergoing both open and laparoscopic (minimally invasive) abdominal hernia repair surgery.

Detailed description

When a person has surgery, there are a few different standard care options for pain relief. Anesthetic (numbing) drugs can be used to cause a loss of feeling in or around a wound but the effect of the numbing medication can be undone.Pain relieving drugs such as acetaminophen (Tylenol), non-steroidal anti-inflammatory drugs (NSAIDs), and opioid (narcotic) medications can also be taken by mouth or through a vein in your arm (intravenous IV.) However, both NSAIDs & Opioid drugs can produce negative side effects such as serious difficulty breathing, stopping breathing altogether, low blood pressure, nausea, vomiting, itching, and constipation. Bupivacaine is one of the commonly used longer-acting numbing medicines (anesthetics). The effect of Bupivacaine or other anesthetics is limited to usually no more than 12 hours when injected around the area of the incision during surgery. Liposomal Bupivacaine (Exparel) could provide good, continuous and longer pain relief than current therapies/treatments commonly used. This can possibly improve patient satisfaction and time to normal activities such as walking.

Interventions

DRUGEXPAREL
DRUGKetorolac
PROCEDURElaparoscopic abdominal hernia repair
PROCEDUREan open surgery for abdominal hernia repair

Sponsors

Pacira Pharmaceuticals, Inc
CollaboratorINDUSTRY
University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo an open or laparoscopic abdominal hernia repair. * Ability to provide informed consent, adhere to study visit schedule, and complete all study assessments.

Exclusion criteria

* Patients with a history of hypersensitivity or idiosyncratic reactions or intolerance to any local anesthetic, opioids or ketorolac. * Patients who abuse alcohol or other drug substance. * Patients who are on chronic opioid therapy (taken an opioid 5 of the last 7 days). * Patients with severe hepatic impairment. * Patients currently pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Patient Satisfaction With Pain Management After SurgeryChange from Surgery to Day 14Satisfaction measured with composite score that includes score from the Likert scale and opioid consumption/satisfaction log. Satisfaction was rated on a scale of 1-5, with 1 being strongly disagree/not satisfied with pain control and 5 being strongly agree/satisfied with pain control. Patients filled out the log on days 1-4 after surgery and at a 7-14 day follow up visit.

Secondary

MeasureTime frameDescription
Total Length of Time in Post-anesthesia Care Unit (PACU)Up to 385 minutes after surgeryLength of time subjects stayed in the PACU following surgery

Countries

United States

Participant flow

Participants by arm

ArmCount
Laparoscopic Treatment Arm
All patients 18 and older presenting with an abdominal hernia requiring laparoscopic repair were screened for inclusion.
7
Laparoscopic Control Arm
All patients 18 and older presenting with an abdominal hernia requiring laparoscopic repair were screened for inclusion.
4
Open Treatment Arm
All patients 18 and older presenting with an abdominal hernia requiring open surgical repair were screened for inclusion.
5
Open Control Arm
All patients 18 and older presenting with an abdominal hernia requiring open surgical repair were screened for inclusion.
3
Total19

Baseline characteristics

CharacteristicLaparoscopic Control ArmOpen Treatment ArmLaparoscopic Treatment ArmOpen Control ArmTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants3 Participants3 Participants1 Participants8 Participants
Age, Categorical
Between 18 and 65 years
3 Participants2 Participants4 Participants2 Participants11 Participants
Age, Continuous62 years74.5 years60.5 years55.5 years64 years
Region of Enrollment
United States
4 Participants5 Participants7 Participants3 Participants19 Participants
Sex: Female, Male
Female
1 Participants0 Participants2 Participants1 Participants4 Participants
Sex: Female, Male
Male
3 Participants5 Participants5 Participants2 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 20 / 50 / 40 / 7
other
Total, other adverse events
0 / 20 / 50 / 40 / 7
serious
Total, serious adverse events
0 / 20 / 50 / 40 / 7

Outcome results

Primary

Patient Satisfaction With Pain Management After Surgery

Satisfaction measured with composite score that includes score from the Likert scale and opioid consumption/satisfaction log. Satisfaction was rated on a scale of 1-5, with 1 being strongly disagree/not satisfied with pain control and 5 being strongly agree/satisfied with pain control. Patients filled out the log on days 1-4 after surgery and at a 7-14 day follow up visit.

Time frame: Change from Surgery to Day 14

ArmMeasureValue (MEDIAN)
Laparoscopic Control ArmPatient Satisfaction With Pain Management After Surgery4 score on a scale
Laparoscopic Treatment ArmPatient Satisfaction With Pain Management After Surgery4 score on a scale
Open Control ArmPatient Satisfaction With Pain Management After Surgery2.5 score on a scale
Open Treatment ArmPatient Satisfaction With Pain Management After Surgery5 score on a scale
Secondary

Total Length of Time in Post-anesthesia Care Unit (PACU)

Length of time subjects stayed in the PACU following surgery

Time frame: Up to 385 minutes after surgery

ArmMeasureValue (MEDIAN)
Laparoscopic Control ArmTotal Length of Time in Post-anesthesia Care Unit (PACU)93.5 minutes
Laparoscopic Treatment ArmTotal Length of Time in Post-anesthesia Care Unit (PACU)64 minutes
Open Control ArmTotal Length of Time in Post-anesthesia Care Unit (PACU)118 minutes
Open Treatment ArmTotal Length of Time in Post-anesthesia Care Unit (PACU)86 minutes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026